Does the evidence support the importance of high transfusion ratios of plasma and platelets to red blood cells in improving outcomes in severely injured patients: a systematic review and meta‐analyses

Abstract

BACKGROUNDDeaths by exsanguination in trauma are preventable with hemorrhage control and resuscitation with allogeneic blood products (ABPs). The ideal transfusion ratio is unknown. We compared efficacy and safety of high transfusion ratios of FFP:RBC and PLT:RBC with low ratios in trauma.STUDY DESIGN AND METHODSMedline, Embase, Cochrane, and Controlled Clinical Trials Register were searched. Observational and randomized data were included. Risk of bias was assessed using validated tools. Primary outcome was 24‐h and 30‐day mortality. Secondary outcomes were exposure to ABPs and improvement of coagulopathy. Meta‐analysis was conducted using a random‐effects model. Strength and evidence quality were graded using GRADE profileRESULTS55 studies were included (2 randomized and 53 observational), with low and moderate risk of bias, respectively, and overall low evidence quality. The two RCTs showed no mortality difference (odds ratio [OR], 1.35; 95% confidence interval [CI], 0.40‐4.59). Observational studies reported lower mortality in high FFP:RBCs ratio (OR, 0.38 [95% CI, 0.22‐0.68] for 1:1 vs. <1:1; OR, 0.42 [95% CI, 0.22‐0.81] for 1:1.5 vs. <1:1.5; and OR, 0.47 [95% CI, 0.31‐0.71] for 1:2 vs. <1:2, respectively). Meta‐analyses in observational studies showed no difference in exposure to ABPs. No data on coagulopathy for meta‐analysis was identified.CONCLUSIONSMeta‐analyses in observational studies suggest survival benefit and no difference in exposure to ABPs. No survival benefit in RCTs was identified. These conflicting results should be interpreted with caution. Studies are mostly observational, with relatively small sample sizes, nonrandom treatment allocation, and high potential for confounding. Further research is warranted.

Plasma Transfusion Practice in Adult Surgical Patients: Systematic Review of the Literature

“…In 2018, McQuilten et al [42] reviewed in their meta-analysis the effect of dose, timing and ratio to RBCs in the therapy with blood components in patients with critical bleeding in the setting of massive transfusion. Similar to a recent meta-analysis from 2019 by de Luz et al [43] the authors could not identify any difference in mortality and morbidity at a transfusion ratio of 1:1:1 (FFP:PLT:RBC) compared to a transfusion ratio of 1:1:2 (FFP:PLT:RBC). Fixed higher ratios of FFP and PLT to RBC are associated with a higher transfusion of FFP and PLT without demonstrating clinical benefit compared to standard care or a 1:1:2 ratio.…”

Evaluating the Tactical Combat Casualty Care principles in civilian and military settings: systematic review, knowledge gap analysis and recommendations for future research

“…Transfusion of allogeneic blood products and use of clotting factor concentrates : Transfusion of red cells, plasma and platelets in a fixed ratio of 2:1:1 or 1:1:1 is currently well established within trauma literature, suggesting that hemostatic resuscitation should be initiated early for patients at risk of bleeding. 101 While products like FWB can be refrigerated, the transport and use of allogenic blood products in prehospital environments still proves logistically difficult and requires further investigation. Recently, the interest in using FWB and cold stored whole blood in trauma resuscitation in prehospital settings has increased.…”

Resuscitation fluids as drugs: targeting the endothelial glycocalyx

“…Clinicians still reluctantly use plasma for fluid resuscitation because it often causes allergic transfusion reactions and other severe adverse events. Plasma administration is most commonly used in trauma patients and has improved the prognosis of such patients in multiple randomized controlled trials [59] . In addition, many animal trials have suggested that plasma can restore the endothelial glycocalyx.…”